The Impact of Vitamin D on Skin Aging

The active metabolites of vitamin D<sub>3</sub> (D<sub>3</sub>) and lumisterol (L<sub>3</sub>) exert a variety of antiaging and photoprotective effects on the skin. These are achieved through immunomodulation and include anti-inflammatory actions, regulation of ke...

Full description

Bibliographic Details
Main Authors: Georgeta Bocheva, Radomir M. Slominski, Andrzej T. Slominski
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/9097
id doaj-3cacd89f304149d29e5c30aa839169f5
record_format Article
spelling doaj-3cacd89f304149d29e5c30aa839169f52021-08-26T13:53:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-01229097909710.3390/ijms22169097The Impact of Vitamin D on Skin AgingGeorgeta Bocheva0Radomir M. Slominski1Andrzej T. Slominski2Department of Pharmacology and Toxicology, Medical University of Sofia, 1431 Sofia, BulgariaDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USADepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USAThe active metabolites of vitamin D<sub>3</sub> (D<sub>3</sub>) and lumisterol (L<sub>3</sub>) exert a variety of antiaging and photoprotective effects on the skin. These are achieved through immunomodulation and include anti-inflammatory actions, regulation of keratinocytes proliferation, and differentiation programs to build the epidermal barrier necessary for maintaining skin homeostasis. In addition, they induce antioxidative responses, inhibit DNA damage and induce DNA repair mechanisms to attenuate premature skin aging and cancerogenesis. The mechanism of action would involve interaction with multiple nuclear receptors including VDR, AhR, LXR, reverse agonism on RORα and -γ, and nongenomic actions through 1,25D<sub>3</sub>-MARRS receptor and interaction with the nongenomic binding site of the VDR. Therefore, active forms of vitamin D<sub>3</sub> including its canonical (1,25(OH)<sub>2</sub>D<sub>3</sub>) and noncanonical (CYP11A1-intitated) D<sub>3</sub> derivatives as well as L<sub>3</sub> derivatives are promising agents for the prevention, attenuation, or treatment of premature skin aging. They could be administrated orally and/or topically. Other forms of parenteral application of vitamin D<sub>3</sub> precursor should be considered to avoid its predominant metabolism to 25(OH)D<sub>3</sub> that is not recognized by CYP11A1 enzyme. The efficacy of topically applied vitamin D<sub>3</sub> and L<sub>3</sub> derivatives needs further clinical evaluation in future trials.https://www.mdpi.com/1422-0067/22/16/9097skin agingphotoagingskin immune responsesvitamin Dvitamin D metabolitesphotoprotection
collection DOAJ
language English
format Article
sources DOAJ
author Georgeta Bocheva
Radomir M. Slominski
Andrzej T. Slominski
spellingShingle Georgeta Bocheva
Radomir M. Slominski
Andrzej T. Slominski
The Impact of Vitamin D on Skin Aging
International Journal of Molecular Sciences
skin aging
photoaging
skin immune responses
vitamin D
vitamin D metabolites
photoprotection
author_facet Georgeta Bocheva
Radomir M. Slominski
Andrzej T. Slominski
author_sort Georgeta Bocheva
title The Impact of Vitamin D on Skin Aging
title_short The Impact of Vitamin D on Skin Aging
title_full The Impact of Vitamin D on Skin Aging
title_fullStr The Impact of Vitamin D on Skin Aging
title_full_unstemmed The Impact of Vitamin D on Skin Aging
title_sort impact of vitamin d on skin aging
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-08-01
description The active metabolites of vitamin D<sub>3</sub> (D<sub>3</sub>) and lumisterol (L<sub>3</sub>) exert a variety of antiaging and photoprotective effects on the skin. These are achieved through immunomodulation and include anti-inflammatory actions, regulation of keratinocytes proliferation, and differentiation programs to build the epidermal barrier necessary for maintaining skin homeostasis. In addition, they induce antioxidative responses, inhibit DNA damage and induce DNA repair mechanisms to attenuate premature skin aging and cancerogenesis. The mechanism of action would involve interaction with multiple nuclear receptors including VDR, AhR, LXR, reverse agonism on RORα and -γ, and nongenomic actions through 1,25D<sub>3</sub>-MARRS receptor and interaction with the nongenomic binding site of the VDR. Therefore, active forms of vitamin D<sub>3</sub> including its canonical (1,25(OH)<sub>2</sub>D<sub>3</sub>) and noncanonical (CYP11A1-intitated) D<sub>3</sub> derivatives as well as L<sub>3</sub> derivatives are promising agents for the prevention, attenuation, or treatment of premature skin aging. They could be administrated orally and/or topically. Other forms of parenteral application of vitamin D<sub>3</sub> precursor should be considered to avoid its predominant metabolism to 25(OH)D<sub>3</sub> that is not recognized by CYP11A1 enzyme. The efficacy of topically applied vitamin D<sub>3</sub> and L<sub>3</sub> derivatives needs further clinical evaluation in future trials.
topic skin aging
photoaging
skin immune responses
vitamin D
vitamin D metabolites
photoprotection
url https://www.mdpi.com/1422-0067/22/16/9097
work_keys_str_mv AT georgetabocheva theimpactofvitamindonskinaging
AT radomirmslominski theimpactofvitamindonskinaging
AT andrzejtslominski theimpactofvitamindonskinaging
AT georgetabocheva impactofvitamindonskinaging
AT radomirmslominski impactofvitamindonskinaging
AT andrzejtslominski impactofvitamindonskinaging
_version_ 1721192463016656896